Breaking News
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Catalent Completes RheinCell Therapeutics Acquisition
Plans to facilitate accelerated access to high-quality iPSC banks with integrated solutions from plasmid DNA manufacturing to clinical supply.08.04.21
-
Breaking News | Clinical Trials | CRO News | Industry News | Information Technology
Syneos Health, Aetion Partner on Regulatory-grade Data, Analytics Solutions
Combines Syneos’ data collection and research services with Aetion Evidence Platform to generate evidence through patient data curation and real-world data.08.04.21
-
Breaking News | Drug Delivery | Drug Development | Drug Discovery | Industry News
BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research
New research groups, PTA and TMI, aim to combat chronic inflammatory diseases and develop oral delivery of macromolar therapeutics.08.04.21
-
Breaking News | Fill/Finish | Industry News
Pii to Offer West’s Daikyo Crystal Zenith Platform
To address the growing demand for high-quality and advanced containment systems, as well as small and medium-sized batches.08.04.21
-
Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
BMS Completes Sale of Couvet Site to WuXi STA
Acquisition significantly enhances WuXi STA's drug product capacity in Europe and enhances capabilities by adding capacity to support global customers.08.04.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi to Acquire Translate Bio for $3.2B
Upgrades drug formulation capabilities and accelerates development of licensed programs in vaccines and potential to explore other therapeutic areas.08.04.21
-
Breaking News | Facilities | Industry News
WuXi STA Completes Acquisition of BMS Manufacturing Facility
State-of-the-art facility in Couvet, Switzerland enhances WuXi STA's drug product capacity in Europe.08.03.21
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing
Nanoform, Boehringer Ingelheim Sign Master Services Agreement
Will address bioavailability and solubility challenges in the pre-clinical early development stages.08.03.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
DisperSol, Catalent Enter Manufacturing Collaboration
To establish KinetiSol technology manufacturing hub for DisperSol’s pipeline.08.03.21
-
Breaking News | Financial Reports
Veklury Drives 2Q Growth for Gilead
Veklury (remdesivir) with sales of $829 million offsets loss of exclusivity of Truvada and Atripla in the U.S. with sales down 72% and 42%, respectively.07.30.21
-
Financial Reports
AbbVie's 2Q Revenue up 34%
New immunology assets Skyrizi and Rinvoq contribute more than $1 billion of combined sales in the quarter.07.30.21
-
Breaking News | Financial Reports
BMS 2Q Revenues up 16%
Top sellers Revlimid, Eliquis and Opdivo drive growth while established brands were down 64%.07.30.21
-
Breaking News | Trials & Filings
Janssen's UPTRAVI IV FDA-Approved for PAH
New therapeutic option allows patients to avoid short-term treatment interruptions and stay on UPTRAVI therapy.07.30.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Global Cell & Gene Therapy Mfg. Market Could Reach $57.4B by 2028
Market estimated to grow at CAGR of 20% from 2021 to 2028 due to an exponential rise in clinical pipeline along with rising number of regulatory approvals.07.30.21
-
Financial Reports
J&J's 2Q Pharma Sales Up 17%
STELARA and DARZALEX sales drive growth with sales up 34% to $2.3 billion and up 59% to $1.4 billion in the quarter, respectively.07.29.21
-
Breaking News | Financial Reports
Pfizer's 2Q Revenues Up 92%
COVID-19 vaccine BNT162b2 contributes $7.8 billion in sales and alliance revenues.07.29.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CellCAN and CCRM Partner to Launch CATTI
New Institute will tackle gaps in training Canada’s GMP workforce.07.29.21
-
Breaking News | Facilities | Industry News
Regeneron Investing $1.8B in Tarrytown, NY Campus
New York's largest biotech company creating an additional 1,000 jobs over five years.07.29.21
-
Breaking News | Facilities | Industry News
Nexus Pharmaceuticals Opens State-of-the-Art Manufacturing Facility
Phase I investment of $100 million supports a new three-story manufacturing facility.07.29.21
-
Breaking News | Facilities | Industry News
Celanese Opens Pharma Drug Delivery Feasibility Lab
State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.07.29.21
